Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study
- 15 March 2012
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 119 (11), 2624-2632
- https://doi.org/10.1182/blood-2011-09-381913
Abstract
The incidence of thrombosis in the purely obstetric form of antiphospholipid syndrome is uncertain. We performed a 10-year observational study of 1592 nonthrombotic women who had experienced 3 consecutive spontaneous abortions before the 10th week of gestation or 1 fetal death at or beyond the 10th week of gestation. We compared the frequencies of thrombotic events among women positive for antiphospholipid Abs (n = 517), women carrying the F5 6025 or F2 rs1799963 polymorphism (n = 279), and women with negative thrombophilia screening results (n = 796). The annual rates of deep vein thrombosis (1.46%; range, 1.15%-1.82%), pulmonary embolism (0.43%; range, 0.26%-0.66%), superficial vein thrombosis (0.44%; range, 0.28%-0.68%), and cerebrovascular events (0.32%; range, 0.18%-0.53%) were significantly higher in aPLAbs women than in the other groups despite low-dose aspirin primary prophylaxis. Women carrying 1 of the 2 polymorphisms did not experience more thrombotic events than women who screened negative for thrombophilia. Lupus anticoagulant was a risk factor for unprovoked proximal and distal deep and superficial vein thrombosis and women in the upper quartile of lupus anticoagulant activity had the highest risk. Despite data suggesting that aPLAbs may induce pregnancy loss through nonthrombotic mechanisms, women with purely obstetric antiphospholipid syndrome are at risk for thrombotic complications.Keywords
This publication has 35 references indexed in Scilit:
- Antiphospholipid syndromeThe Lancet, 2010
- How I treat the antiphospholipid syndromeBlood, 2009
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Recurrent miscarriage and long-term thrombosis risk: a case–control studyHuman Reproduction, 2005
- Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control studyBlood, 2003
- High thrombosis rate after fetal loss in antiphospholipid syndrome: Effective prophylaxis with aspirinArthritis & Rheumatism, 2001
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registryAmerican Journal Of Medicine, 1996
- Criteria for the Diagnosis of Lupus Anticoagulants: An UpdateThrombosis and Haemostasis, 1995
- Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus AnticoagulantsThrombosis and Haemostasis, 1995